Results 211 to 220 of about 40,773 (330)

The Effect of Proprotein Convertase Subtilisin/Kexin Type 9 Inhibitors on Nonfasting Remnant Cholesterol in a Real World Population [PDF]

open access: yes, 2018
Background. Proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitors have demonstrated significant effects on low-density lipoprotein (LDL) cholesterol and nonhigh density lipoprotein (HDL) cholesterol. To date, there have been limited reports on
Holmes, Sari D   +3 more
core   +1 more source

A Proprotein Convertase Subtilisin-like/Kexin Type 9 (PCSK9) C-terminal Domain Antibody Antigen-binding Fragment Inhibits PCSK9 Internalization and Restores Low Density Lipoprotein Uptake [PDF]

open access: hybrid, 2010
Ni Yan   +24 more
openalex   +1 more source

NUPR1 Promotes Radioresistance in Colorectal Cancer Cells by Inhibiting Ferroptosis

open access: yesJournal of Cellular and Molecular Medicine, Volume 29, Issue 7, April 2025.
ABSTRACT Radioresistance is a major clinical challenge and the underlying mechanism has not been thoroughly elucidated. In this study, a radioresistant (RR) cell line is established to explore the transcriptomic signatures of radioresistance in colorectal cancer (CRC).
Yimin Fang   +11 more
wiley   +1 more source

Severe Hypercholesterolemia in Four British Families With the D374Y Mutation in the PCSK9 Gene

open access: bronze, 2005
R.P. Naoumova   +7 more
openalex   +1 more source

PCSK9 LNA Antisense Oligonucleotides Induce Sustained Reduction of LDL Cholesterol in Nonhuman Primates [PDF]

open access: hybrid, 2011
Marie Lindholm   +9 more
openalex   +1 more source

Role of PNPLA3 in Hepatic Stellate Cells and Hepatic Cellular Crosstalk

open access: yesLiver International, Volume 45, Issue 4, April 2025.
ABSTRACT Aims Since its discovery, the patatin‐like phospholipase domain containing 3 (PNPLA3) (rs738409 C>G p.I148M) variant has been studied extensively to unravel its molecular function. Although several studies proved a causal relationship between the PNPLA3 I148M variant and MASLD development and particularly fibrosis, the pathological mechanisms ...
Maria Castanho Martins   +5 more
wiley   +1 more source

Variant within CELSR2/PSRC1/SORT1, but not within CILP2/PBX4, PCSK9 and APOB genes, has a potential to influence statin treatment efficacy [PDF]

open access: bronze, 2012
Jaroslav A. Hubáček   +8 more
openalex   +1 more source

Proprotein Convertase Subtilisin/Kexin Type 9 (PCSK9) Gene Is a Risk Factor of Large-Vessel Atherosclerosis Stroke

open access: gold, 2007
Shérine Abboud   +8 more
openalex   +2 more sources

PCSK9 regulates neuronal apoptosis by adjusting ApoER2 levels and signaling [PDF]

open access: bronze, 2012
Kai Kysenius   +4 more
openalex   +1 more source

Home - About - Disclaimer - Privacy